Volitionrx Net Working Capital from 2010 to 2024

VNRX Stock  USD 0.70  0.01  1.45%   
Volitionrx Net Working Capital yearly trend continues to be fairly stable with very little volatility. Net Working Capital is likely to outpace its year average in 2024. During the period from 2010 to 2024, Volitionrx Net Working Capital regression line of annual values had significance of  0.07 and arithmetic mean of  6,423,793. View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
-10 M
Current Value
-9.5 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Volitionrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Volitionrx's main balance sheet or income statement drivers, such as Interest Expense of 232.7 K, Other Operating Expenses of 38.6 M or Total Operating Expenses of 38.6 M, as well as many indicators such as Price To Sales Ratio of 62.58, Dividend Yield of 0.0 or Days Sales Outstanding of 122. Volitionrx financial statements analysis is a perfect complement when working with Volitionrx Valuation or Volatility modules.
  
Check out the analysis of Volitionrx Correlation against competitors.
For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Latest Volitionrx's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Volitionrx over the last few years. It is Volitionrx's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Volitionrx's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Volitionrx Net Working Capital Regression Statistics

Arithmetic Mean6,423,793
Coefficient Of Variation125.17
Mean Deviation5,860,285
Median8,276,737
Standard Deviation8,040,352
Sample Variance64.6T
Range25.4M
R-Value(0.48)
Mean Square Error53.7T
R-Squared0.23
Significance0.07
Slope(860,727)
Total Sum of Squares905.1T

Volitionrx Net Working Capital History

2024-9.5 M
2023-10 M
2022-5.2 M
202115.5 M
202014.1 M
201913.7 M
201811.6 M

About Volitionrx Financial Statements

Volitionrx investors use historical fundamental indicators, such as Volitionrx's Net Working Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Volitionrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital-10 M-9.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.